Research Article
Platelet-Rich Plasma in the Treatment of Subcutaneous Venous Access Device Scars: A Head-to-Head Patient Survey
Table 2
Results of the primary endpoints (quality-of-life decrease and pain in port area) for the control group and the PRP (Arthrex ACP) group.
|